Vasodilation Effect of Inhalational Anesthetics
Information source: Nanjing Medical University
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: General Anesthesia
Intervention: Halothane (Drug); Isoflurane (Drug); Sevoflurane (Drug); Desflurane (Drug); Enflurane (Drug)
Phase: N/A
Status: Completed
Sponsored by: Nanjing Medical University Official(s) and/or principal investigator(s): XiaoFeng Shen, MD, Study Director, Affiliation: Nanjing Medical University
Summary
Previous studies on animals suggest that inhalational anesthetics can reduce vascular
tension in vitro resulting in vasodilation and decrease in blood pressure. This role for
inhalational anesthetics has essential clinical implications such as the condition of sepsis
or septic shock or other shock-associated states during which the blood vessel constricts
strongly and leads to circulation dysfunction. The vasodilation property of these
anesthetics including halothane, isoflurane, sevoflurane, desflurane and enflurane enables
them to be better options than other general anesthetics in many clinical conditions needing
the vasculature to be dilated. The investigators hypothesized that these inhalational
anesthetics can evoke vasodilation measured with ultrasonography during general anesthesia
in vivo as the in vitro studies displayed.
Clinical Details
Official title: Vasodilation Effect of Inhalational Anesthetics Including Halothane, Isoflurane, Sevoflurane, Desflurane and Enflurane
Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Primary outcome: Ultrasonography of blood vessels including radial artery, brachial artery, femoral artery, popliteal artery
Secondary outcome: Blood flow volume during anesthesia of the vasculatureBlood pressure including systolic, diastolic and mean artery blood pressures The time interval of between the initiation of the inhalational anesthetics delivered to the beginning of decreasing of blood pressure The total dose of phenylephrine required to maintain baseline arterial blood pressure Regression and correlation analyses between different doses of the anesthetics and the extent of vasodilation
Eligibility
Minimum age: 19 Years.
Maximum age: 45 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Must be undergoing general anesthesia
- Age between 19-45 years
Exclusion Criteria:
- With hypertension
- Existing organic dysfunction
- Allergic to inhalant anesthetics
- Alcohol addictive or narcotic dependent patients
- A history of the use of centrally-acting drugs of any sort, chronic pain and
psychiatric diseases records
Locations and Contacts
Nanjing Maternal and Child Health Care Hospital, Nanjing, Jiangsu 210004, China
Additional Information
Starting date: December 2008
Last updated: December 22, 2009
|